Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end?

por Drougkas, Konstantinos, Karampinos, Konstantinos, Karavolias, Ioannis, Koumprentziotis, Ioannis-Alexios, Ploumaki, Ioanna, Triantafyllou, Efthymios, Trontzas, Ioannis, Kotteas, Elias
Publicado 2022

Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment

por Ziogas, Dimitrios C., Theocharopoulos, Charalampos, Lialios, Panagiotis-Petros, Foteinou, Dimitra, Koumprentziotis, Ioannis-Alexios, Xynos, Georgios, Gogas, Helen
Publicado 2023

Bcl-2 pathway inhibition in solid tumors: a review of clinical trials

por Ploumaki, Ioanna, Triantafyllou, Efthymios, Koumprentziotis, Ioannis-Alexios, Karampinos, Konstantinos, Drougkas, Konstantinos, Karavolias, Ioannis, Trontzas, Ioannis, Kotteas, Elias A.
Publicado 2023